|
FULC Fulcrum Therapeutics Inc 1680581 |
| Balance Sheet |
|
Current Assets
|
267,489,000 |
|
Assets
|
279,008,000 |
|
Current Liabilities
|
14,509,000 |
|
Liabilities
|
21,717,000 |
|
Equity
|
257,291,000 |
|
Shares Out
|
62,401,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
14,543,000 |
|
Investing Cash Flow
|
29,970,000 |
| Market Analysis |
Market Cap
|
220,274,645 |
|
Price
|
3.96 |
|
BVPS
|
4.12 |
|
PB
|
0.96 |
|
EPS
|
-0.35 |
|
PS
|
9.75 |
|
FCF
|
44,513,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view FULC documents filed with the SEC.
FULC Filings
Clear
